Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279447 · ClinicalTrials.gov registry record · Phase 4
Infrapatellar Nerve Block for Post-operative Knee Arthroscopy Pain Control
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
NCT01279447 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 68 participants.
The verdict
NCT01279447, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether infrapatellar branch of the saphenous nerve blocks are effective in decreasing analgesic use, promoting earlier mobility, and improving long term outcome scores after knee arthroscopy.
Interventions
- DRUG Normal Saline
- DRUG 0.25% Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01279447
The ClinicalTrials.gov registry entry for NCT01279447 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT01279447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01279447 about?
NCT01279447 is a clinical study titled "Infrapatellar Nerve Block for Post-operative Knee Arthroscopy Pain Control". The purpose of this study is to determine whether infrapatellar branch of the saphenous nerve blocks are effective in decreasing analgesic use, promoting earlier mobility, and improving long term outcome scores after knee arthroscopy.
What is the current status of trial NCT01279447?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2011-01. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01279447?
The interventions under investigation include: Normal Saline (DRUG), 0.25% Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT01279447?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.